RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456,613 | +18.2% | 59,688 | +15.4% | 0.00% | – |
| Q2 2023 | $386,311 | -34.7% | 51,715 | -41.7% | 0.00% | – |
| Q1 2023 | $591,362 | +8.1% | 88,660 | +24.9% | 0.00% | – |
| Q4 2022 | $547,201 | -11.5% | 70,973 | +22.2% | 0.00% | – |
| Q3 2022 | $618,000 | +18.2% | 58,070 | -9.7% | 0.00% | – |
| Q2 2022 | $523,000 | +11.0% | 64,318 | -2.3% | 0.00% | – |
| Q1 2022 | $471,000 | -62.2% | 65,799 | -9.6% | 0.00% | -100.0% |
| Q4 2021 | $1,247,000 | +223.9% | 72,801 | +334.3% | 0.00% | – |
| Q3 2021 | $385,000 | -19.6% | 16,762 | +27.7% | 0.00% | – |
| Q2 2021 | $479,000 | – | 13,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $26,790,000 | 44.35% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $50,694,446,000 | 9.21% |
| Samsara BioCapital, LLC | 775,583 | $28,309,000 | 3.50% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $55,088,000 | 3.17% |
| Laurion Capital Management LP | 3,858,617 | $140,839,000 | 0.78% |
| Casdin Capital, LLC | 548,156 | $20,008,000 | 0.51% |
| ALLEN OPERATIONS LLC | 68,104 | $2,486,000 | 0.43% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 472,552 | $17,248,000 | 0.40% |
| Ratan Capital Management LP | 110,000 | $4,015,000 | 0.35% |
| Comprehensive Financial Management LLC | 1,109,395 | $40,493,000 | 0.34% |